[Multicenter study of the effectiveness of antiscar therapy in patients at different age periods].

Autor:	Minaev SV; Stavropol State Medical University, Stavropol, Russia., Vladimirova OV; Stavropol State Medical University, Stavropol, Russia., Kirgizov IV; Russian Medical Academy of Continuous Professional Education, Moscow, Russia., Akselrov MA; Tyumen State Medical University, Tyumen, Russia., Razin MP; Kirov State Medical University, Kirov, Russia., Ivchenko AA; Stavropol State Medical University, Stavropol, Russia., Timofeev SI; State Budgetary Institution of Healthcare Magadan Children Regional Hospital, Magadan, Russia., Tarakanov VA; Kuban State Medical University, Krasnodar, Russia., Barova NK; Kuban State Medical University, Krasnodar, Russia., Obedin AN; Stavropol State Medical University, Stavropol, Russia., Zelenskaya MV; Stavropol State Medical University, Stavropol, Russia.
Jazyk:	ruština
Zdroj:	Khirurgiia [Khirurgiia (Mosk)] 2020 (9), pp. 51-58.
DOI:	10.17116/hirurgia202009151
Abstrakt:	Objective: Was to evaluate the effectiveness of anti-scar treatment with Contractubex gel in children and adults. Material and Methods: A group of researchers based on clinical hospitals and university medical clinics carry out the multicenter study to evaluate the effectiveness of anti-scar treatment with Contractubex gel containing cepalin, allantoin and heparin, with its early appointment in groups of children from 12 to 18 years old and adults from 21 to 35 years old. The study included data from 216 patients. Patients of both age groups were initially divided into two: the main and control ones with an equal distribution according to the type of surgical intervention (hernia repair and appendectomy), age, gender, and anamnestic data. The dynamic observation was carried out using two rating scales - filled out by a doctor (Vancouver scale) and a patient (author's rating scale in the Scar Diary mobile application). Results: Based on the results of the analysis of the data obtained, a high efficiency of the use of Contractubex gel at the early stages of scar formation among patients of the main group in comparison with the control was revealed. By 90 days, the treatment result according to the Vancouver scale was 0,16±0,1 points in the main group and 0,39±0,2 points in the control group. At the same time, with a dynamic scale for assessing the cicatricial process, there was a significant ( p <0.05) improvement in the main group (0,2±0,06 points) compared with the control group (0,6±0,17 points). In addition, was noticed the strong commitment to anti-scar treatment in pediatric patients. Conclusions: The work confirms the undoubted need for anti-scar treatment in the early stages of scar formation after surgical interventions, which accelerates the psychophysical rehabilitation of patients after surgery and improves the quality of life.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu